BioLife Solutions (BLFS) PT Raised to $64 at Cowen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/17/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Rating Summary:
7 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 22 | New: 41
Join SI Premium – FREE
Cowen analyst Chris Lin raised the price target on BioLife Solutions (NASDAQ: BLFS) to $64.00 (from $50.00) while maintaining an Outperform rating.
The analyst commented, "BLFS delivered a healthy Q2 beat versus Street expectations, driven by strong organic growth (+49% Y/Y) and nearly +200 new customers wins (compared to +80 in Q1 and +213 in FY'20). BLFS lifted its F2021 revenue guidance by +$2M to reflect its recent acquisition of Sexton Biotechnologies, which leaves potential room for a beat-and-raise in Q3, in our view. Outperform; PT to $64."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- C.H. Robinson Worldwide (CHRW) PT Lowered to $160 at BMO Capital
- WEC Energy Group (WEC) PT Lowered to $109 at BMO Capital
- Travelers (TRV) PT Raised to $372 at Evercore ISI
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
Cowen & Co, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
